Roberto Mateo is a highly experienced director in the Department of Clinical Virology at Gilead Sciences, overseeing various HBV/HDV and herpesvirus-related projects from pre-clinical development to post-marketing support since December 2019. Responsibilities include leading virology teams on non-clinical NDA filings, directing clinical trials, and authoring regulatory documents. Prior experience includes roles as Associate Director and Senior Scientist at Vaxart Inc., focusing on translational research in vaccine development, and significant research positions at Stanford University School of Medicine. Education includes a Ph.D. in Molecular Biology from Universidad Autónoma de Madrid and a B.Sc. in Biochemistry from Universidad del País Vasco.
This person is not in any teams
This person is not in any offices